Form 4: Coherent Corp. Chief Innovation Officer Sells Shares Under 10b5-1 Plan

Coherent Corp.'s Chief Innovation Officer, Christopher Koeppen, sold 2,590 shares of common stock at $107 per share on December 3, 2024, under a pre-arranged 10b5-1 trading plan.

Summary

• Christopher Koeppen, the Chief Innovation Officer of Coherent Corp., sold 2,590 shares of common stock on December 3, 2024.
• The sale was executed at a price of $107 per share.
• This transaction was conducted under a Rule 10b5-1 trading plan that was adopted on June 15, 2023.
• Following the transaction, Mr. Koeppen still directly owns 60,502 shares of Coherent Corp. common stock.
• He also indirectly owns shares through his daughter and son.

Sentiment

Score: 5

Explanation: The document is a routine disclosure of an insider stock sale under a pre-arranged plan, which is neither positive nor negative for the company's outlook.

Industry Context

This is a routine disclosure of an insider stock sale, which is common for executives of publicly traded companies. The use of a 10b5-1 plan indicates the sale was pre-planned and not based on any recent material non-public information.

Comparison to Industry Standards

• The use of a 10b5-1 trading plan is a standard practice for corporate insiders to avoid accusations of trading on non-public information.
• Many executives at publicly traded companies, such as those in the technology sector like Applied Materials or Lam Research, utilize similar plans for their stock transactions.
• The volume of shares sold is relatively small compared to the total shares outstanding, suggesting it is a routine transaction rather than a significant divestment.

Stakeholder Impact

• The stock sale by an executive may have a minor impact on shareholder sentiment, but it is unlikely to significantly affect the company's stock price due to the pre-planned nature of the transaction.

Key Dates

Keywords

insider trading, stock sale, Rule 10b5-1, Coherent Corp, Christopher Koeppen, equity securities